These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9242803)

  • 1. Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR.
    Schwartz DH; Laeyendecker OB; Arango-Jaramillo S; Castillo RC; Reynolds MJ
    Lancet; 1997 Jul; 350(9073):256-9. PubMed ID: 9242803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.
    Drosten C; Seifried E; Roth WK
    J Clin Microbiol; 2001 Dec; 39(12):4302-8. PubMed ID: 11724836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.
    Khurana S; Needham J; Mathieson B; Rodriguez-Chavez IR; Catanzaro AT; Bailer RT; Kim J; Polonis V; Cooper DA; Guerin J; Peterson ML; Gurwith M; Nguyen N; Graham BS; Golding H
    J Virol; 2006 Mar; 80(5):2092-9. PubMed ID: 16474117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant test findings in early infant diagnosis of HIV in a national reference laboratory in Kenya: challenges and opportunities for programs.
    Kageha S; Okoth V; Kadima S; Vihenda S; Okapesi E; Nyambura E; Maiyo A; Ndung'u N; Khamadi S; Mwau M
    J Trop Pediatr; 2012 Aug; 58(4):247-52. PubMed ID: 22052701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an immunoassay for differentiating human immunodeficiency virus infections--from vaccine-induced immune response in Tiantan vaccine trials in China.
    Yuan Z; Chen W; Zhang J; Zhang J; Xiang T; Hu J; Wu Z; Du X; Huang A; Zheng J
    Clin Biochem; 2012 Oct; 45(15):1219-24. PubMed ID: 22627200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert.
    Kim HN; Tabet SR; Corey L; Celum CL
    Vaccine; 2006 Jan; 24(4):532-9. PubMed ID: 16242816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay.
    Böni J; Pyra H; Schüpbach J
    J Med Virol; 1996 May; 49(1):23-8. PubMed ID: 8732867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The quest for an HIV vaccine].
    Girard MP
    Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction (PCR) as a diagnostic tool in HIV infection.
    Vandamme AM
    Verh K Acad Geneeskd Belg; 1994; 56(3):231-65. PubMed ID: 7519811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.
    Pilcher CD; McPherson JT; Leone PA; Smurzynski M; Owen-O'Dowd J; Peace-Brewer AL; Harris J; Hicks CB; Eron JJ; Fiscus SA
    JAMA; 2002 Jul; 288(2):216-21. PubMed ID: 12095386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent progress in HIV screening tests and nucleic acid tests].
    Imai M; Kato S
    Nihon Rinsho; 2010 Mar; 68(3):433-8. PubMed ID: 20229786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
    Cooper CJ; Metch B; Dragavon J; Coombs RW; Baden LR;
    JAMA; 2010 Jul; 304(3):275-83. PubMed ID: 20639561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 seronegativity in a child with proved perinatal HIV infection on HAART.
    Desai N; Mathur M; Abu-Lawi K
    Sex Transm Infect; 2005 Oct; 81(5):377-9. PubMed ID: 16199735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV reverse transcriptase activity assay: a feasible surrogate for HIV viral load measurement in China.
    Huang D; Zhuang Y; Zhai S; Song Y; Liu Q; Zhao S; Wang S; Li X; Kang W; Greengrass V; Plate M; Crowe SM; Sun Y
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):208-13. PubMed ID: 20846816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots.
    Lilian RR; Bhowan K; Sherman GG
    J Clin Virol; 2010 May; 48(1):40-3. PubMed ID: 20211580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.